Search company, investor...


Founded Year



Incubator/Accelerator | Alive

Total Raised


About Pregnolia

Pregnolia is a medical device company that focuses on the development and commercialization of a diagnostic device to identify women at risk for preterm delivery early in pregnancy such that gynecologists can make key decisions about preterm birth management. It aims to reduce the number of premature births. It was founded in 2016 and is based in Zurich, Switzerland.

Headquarters Location

Wiesenstrasse 33

Zurich, 8952,



Missing: Pregnolia's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pregnolia's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Pregnolia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pregnolia is included in 4 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.


Medical Devices

8,537 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,502 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

7,901 items

Latest Pregnolia News

Sanitas invests in Pregnolia

May 11, 2021

News Schlieren ZH – The health insurance provider Sanitas is supporting a device from the MedTech start-up Pregnolia that is used to detect premature births. It is taking on the costs of the check-up and investing in the company. Pregnolia  has developed an instrument to detect the risks of premature birth. To do so, a probe measures the stiffness of the cervix. If it is too soft, the physician can initiate therapeutic measures in good time. One of the start-up’s aims is to identify asymptomatic women who could benefit from intervention in the early stages of pregnancy. Sanitas  is the first health insurance provider in Switzerland to take on the costs of a check-up using the Pregnolia device according to a press release . This is covered within outpatient supplementary insurance. Sanitas is also investing in Pregnolia. According to an article on, there are plans for a “modest” investment. Pregnolia was already able to secure 4 million Swiss francs in a funding round last summer. Sabrina Badir, CEO and Founder of Pregnolia, is quoted as saying: ““We’re delighted that Sanitas is supporting our startup as we ready the product for broad market release and that, by reimbursing check-ups done using our technology, it is sending out a strong signal for innovation in the market.” Badir founded Pregnolia as a spin-off from the Swiss Federal Institute of Technology in Zurich ( ETH ). The start-up is headquartered in Schlieren. Related news

Pregnolia Frequently Asked Questions (FAQ)

  • When was Pregnolia founded?

    Pregnolia was founded in 2016.

  • Where is Pregnolia's headquarters?

    Pregnolia's headquarters is located at Wiesenstrasse 33, Zurich.

  • What is Pregnolia's latest funding round?

    Pregnolia's latest funding round is Incubator/Accelerator.

  • How much did Pregnolia raise?

    Pregnolia raised a total of $7.7M.

  • Who are the investors of Pregnolia?

    Investors of Pregnolia include Tech4eva Accelerator, Sanitas, Zurcher Kantonalbank, Verve Ventures, CADFEM and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.